We are dedicated to ensuring that our patients benefit from the latest scientific advancements and receive the most effective treatments for their recovery.
ONCOLOGY CONSULTATION – The most advanced therapy planning currently available in Hungary
WHO IS WELCOME TO THE ONCOLOGY CONSULTATION AT MIND KLINIKA?
- If you are a cancer patient, or a relative of one, and understandably wish to seek a second opinion before starting therapy, explore the options offered by personalized treatments, or learn about an individualized diet plan designed by doctors and dietitians to support recovery you have the right and the opportunity to request a second opinion. It is important to be confident that your therapy is on the right track.
- If a tumor has recently been detected, or if the disease is only suspected and you want to act quickly, MiND Klinika can help. While the state healthcare system may take 4–6 months before treatment can begin, our clinic can complete the full oncological diagnostics within a week, enabling our oncology team to develop a treatment plan. In the case of cancer, reducing the time to treatment from months to just a few weeks can significantly increase the chances of recovery: saving time means saving lives.Our clinic is equipped with the most advanced imaging diagnostic tools, including a uniquely modern 3-tesla MRI machine in Central and Eastern Europe, whose resolution and software capabilities allow for fast and precise diagnosis.
- If you want to know as soon as possible how effective your ongoing therapy is, we also offer therapy monitoring. Using this MRI machine, we can even detect the therapeutic response in the body just two weeks after starting treatment. In other words, unlike standard practice, you don’t have to wait three months to find out if the treatment is working results can be available in as little as 14 days, allowing your doctor to adjust the therapy if necessary.
- If you wish to assess your current health status for preventive purposes whether out of general health awareness or due to a family history of cancer you can take advantage of the screening services provided by our clinic.
The molecular tumor board at MiND Klinika an expert team of physicians plays an active role in developing the treatment plan, enabling the selection of the most effective therapy based on the latest available scientific evidence.
Our strategic partner is Genomate Health.
Digital therapy planning identifies the detected genetic mutations and the therapies associated with them, ranking available drugs by effectiveness with the help of artificial intelligence. Genomate Health is revolutionizing cancer research and personalized treatment: their AI-driven platform enables every patient to receive the most effective, targeted therapy based on their unique genetic profile. Using the Genomate algorithm, physicians can review all genetic alterations of a tumor within seconds and receive a ranked, personalized treatment recommendation based on the latest scientific evidence giving patients the best chance for optimal outcomes while avoiding unnecessary therapies.
Thanks to its international recognition, development centers in the United States and Hungary, and world-leading innovations, Genomate Health now makes the benefits of precision oncology available to thousands of patients. This technology not only allows faster and more informed decisions for physicians but also truly saves lives: clinical data show that treatments recommended by Genomate significantly increase therapeutic success rates and offer new hope to cancer patients worldwide.
What happens when you attend an oncology consultation at MiND Klinika?
- You will receive an appointment for the consultation within a few days, either by phone or through our website.
- Prior to the in-person meeting, we will, whenever possible, request your medical history and any relevant documents, so that our clinician can be fully prepared to see you.
- At your first personal consultation, you will meet with a MiND physician to discuss the available options. If necessary, they may recommend further examinations.
- If personalized treatment is a viable option for your case, MiND Klinika can provide a precision oncology opinion, which can assist your treating physician in developing a therapy plan. This opinion, based on molecular diagnostics, is generated using the Oncompass software and a collaborative expert medical team, which can also involve your current physician in the decision-making process.
- Your MiND clinician will explain the expert team’s opinion, the recommended therapy, and other options to support your recovery.
- To ensure the therapy process is as effective as possible, MiND Klinika offers regular consultations and therapy monitoring at key points of your oncology treatment, so that you can be confident your therapy is progressing appropriately, efficiently, and in the right direction.
USEFUL AND INTERESTING CONTENT RELATED TO ONCOLOGY:
Basics for Our Oncology Consultation
Dr. Gábor Pajkos, Medical Director at Oncompass Medicine and oncologist at MiND Klinika, shares a few key points that are useful to know before attending an oncology consultation.
The Role of Molecular Diagnostics in Colorectal Cancer Treatment
The genetic alterations underlying tumors vary from person to person. As a result, tumor behavior, therapeutic response, and progression can differ even among patients with the same diagnosis. Molecular diagnostics allow us to identify these genetic alterations, supporting personalized treatment and helping select the most effective therapy for each patient. The precision oncology decision-support opinion available at MiND Klinika assists treating physicians in choosing the appropriate therapy.
In this video, Dr. Gábor Pajkos, oncologist, and Dr. Richárd Schwab, gastroenterologist and internist, discuss this topic.
Most Sensitive Imaging Methods in Colorectal Cancer Diagnostics
Before surgery, tumor assessment is typically performed using CT scans, but today functional imaging methods (PET-CT, diffusion MRI) also help distinguish between different underlying morphological changes, such as scar tissue, inflammation, or tumor. MRI has brought a breakthrough in this area, enabling highly sensitive imaging comparable to PET-CT without radiation exposure.
In addition to these sensitive imaging techniques, molecular testing can detect very early recurrences or metastases that are not yet visible on imaging. MiND Klinika offers this full diagnostic spectrum, based on the latest results, to its patients.
It is worth watching the discussion between Dr. Gábor Pajkos, oncologist, and Dr. Richárd Schwab, gastroenterologist and internist.
Modern Diagnostics of Pancreatic Tumors Play a Key Role in Choosing the Right Therapy and Influencing Prognosis
Pancreatic cancer is a disease with a very poor prognosis, often diagnosed late when the disease is already advanced, limiting treatment options and reducing prognostic prospects. Molecular diagnostics can identify genetic alterations that have therapeutic significance. By examining therapeutic targets through molecular diagnostic testing, determining treatment sensitivity and responsiveness can fundamentally change the outcome of therapy.
Dr. Gábor Pajkos, oncologist, and Dr. Richárd Schwab, gastroenterologist and internist, discuss this topic in the video.
One of the founders and the Scientific Director of Genomate Health is Professor István Peták, a molecular pharmacologist and member of the MiND Klinika Scientific Advisory Board. Genomate is an artificial intelligence–based medical tool a clinical decision-support system that identifies and determines which personalized therapy will be most effective for cancer patients, thereby assisting the medical team in designing an optimal treatment plan.
PERSONALIZED MEDICINE: HOPES AND REALITY IN 2022
We hear and read a lot about personalized treatment for cancer patients. There isn’t a week without new scientific findings or new drugs emerging in the field. But can we already say that the future has arrived? Do Hungarian patients also have access to personalized care?
The article on Webbeteg can be read at the following link. Journalist Anita Gorzsás speaks with Dr. Richárd Schwab, internist and gastroenterologist at our clinic:
ARTICLE: https://www.webbeteg.hu/cikkek/daganat/27849/szemelyre-szabott-gyogyaszat
Dr. Lengyel Erzsébet
Oncologist
